date,title,source
Oct-18-18,Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine,GlobeNewswire
Oct-18-18,"Report: Developing Opportunities within Natera, InnerWorkings, Chanticleer, NN, Stoneridge, and Avid Technology  Future Expectations, Projections Moving into 2018",GlobeNewswire
Oct-31-18,Premier Bay Area biotech developer tees up next major project,American City Business Journals
Nov-01-18,Natera Announces Third Quarter 2018 Earnings Conference Call,PR Newswire
Nov-08-18,"Natera (NTRA) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-08-18,Natera: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Natera Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-09-18,Earnings Results Make 3 Stocks Move Friday,GuruFocus.com
Nov-12-18,Edited Transcript of NTRA earnings conference call or presentation 8-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-13-18,Edited Transcript of NTRA earnings conference call or presentation 8-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-14-18,Edited Transcript of NTRA earnings conference call or presentation 8-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,PerkinElmer's Vanadis NIPT CE Mark Boosts Prenatal Prospects,Zacks
Nov-28-18,"New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-28-18,Natera Receives Unique Z-Code for Its Kidney Transplant Rejection Monitoring Test,PR Newswire
Nov-29-18,"Natera Achieves Enrollment Goal of 20,000 Patients in SMART Study",PR Newswire
Dec-06-18,Natera Presents Breast Cancer Data at SABCS Showing Ability of Signatera (RUO) to Detect Molecular Residual Disease Up to Two Years Prior to Clinical Relapse and Predict Treatment Response,PR Newswire
Dec-25-18,"Who Has Been Selling Natera, Inc. (NASDAQ:NTRA) Shares?",Simply Wall St.
